AstraZeneca’s COVID-19 vaccine got the green light in India.
The government said on Saturday that experts in the field of drug regulation recommend the vaccine developed by AstraZeneca and Oxford University, as well as one supported by a state institution.
The government of the world’s most populous country has said the final decision rests with the head of the Central Drugs Standards Control Organization, but the process is expected to be a formality.
The AstraZeneca vaccine, which was only approved by Britain on Wednesday, is cheaper and easier to use than some competing shots. But it is plagued by uncertainty about its most effective dose. It is made locally by the Serum Institute of India.
The other vaccine is known as COVAXIN. It was developed locally by Bharat Biotech and the Government-run Indian Medical Research Council. Little is known about the results of his clinical trials.
India’s Information and Broadcasting Minister Prakash Javadekar said two other vaccines were awaiting approval, one from India and the other from Russia.
‘India is perhaps the only country where four vaccines are being prepared at once. Yesterday, Serum’s COVISHIELD was approved for emergency use. ”
The regulator of India has also received an emergency application for the vaccine made by Pfizer and BioNTech. The one was the first to get regulatory approval in the West.
Video transcription
– AstraZeneca’s COVID-19 vaccine got the green light in India. The government said experts in the field of drug regulation on Saturday recommended the vaccine developed by AstraZeneca and Oxford University, as well as one backed by a state institution. The government of the world’s most populous country has said that the final decision rests with the head of the Central Drugs Standards Control Organization. But the process is expected to be a formality.
The AstraZeneca vaccine, which was only approved by Britain on Wednesday, is cheaper and easier to use than some competing shots. But it is plagued by uncertainty about its most effective dose. It is made locally by the Serum Institute of India.
The other vaccine is known as COVAXIN. It was developed locally by Bharat Biotech and the Government-run Indian Medical Research Council. Little is known about the results of his clinical trials.
India’s Information and Broadcasting Minister Prakash Javadekar said two other vaccines were awaiting approval – one from India and the other from Russia.
PRAKASH JAVADEKAR: [NON-ENGLISH SPEECH]
INTERPRETER: India is perhaps the only country where four vaccines are being prepared at once. Yesterday, Serum’s COVISHIELD was approved for emergency use.
– The Indian regulator has also received an emergency application for the vaccine made by Pfizer and BioNTech. The one was the first to get regulatory approval in the West.